Guangdong VTR Bio-Tech Co., Ltd. (SHE:300381)
6.11
-0.07 (-1.13%)
Apr 22, 2026, 10:15 AM CST
Guangdong VTR Bio-Tech Market Cap
Guangdong VTR Bio-Tech has a market cap or net worth of 2.97 billion as of April 21, 2026. Its market cap has decreased by -14.17% in one year.
Market Cap
2.97B
Enterprise Value
2.43B
Revenue
830.87M
Ranking
n/a
PE Ratio
456.71
Stock Price
6.11
Market Cap Chart
Since January 28, 2014, Guangdong VTR Bio-Tech's market cap has increased from 1.84B to 2.97B, an increase of 61.33%. That is a compound annual growth rate of 3.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 2.97B | -5.21% |
| Dec 31, 2025 | 3.13B | -7.12% |
| Dec 31, 2024 | 3.37B | -4.55% |
| Dec 29, 2023 | 3.53B | -4.20% |
| Dec 30, 2022 | 3.69B | -36.63% |
| Dec 31, 2021 | 5.82B | 9.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novoprotein Scientific | 3.49B |
| Yantai Zhenghai Biotechnology | 3.49B |
| Shenzhen Bioeasy Biotechnology | 3.39B |
| Shanghai Model Organisms Center | 3.27B |
| Landfar Bio-medicine | 3.23B |
| Cabio Biotech (Wuhan) | 3.16B |
| Jiangsu Sihuan Bioengineering | 3.12B |
| Suzhou Fushilai Pharmaceutical | 2.87B |